Point-of-care testing (POCT) is essential for the rapid detection of analytes near to the patient, which facilitates better disease diagnosis, monitoring, and management. It enables quick medical decisions, as the diseases can be diagnosed at a very early stage, leading to improved health outcomes for patients by enabling the early start of treatment. The global Point-of-Care Diagnostics market was valued at $21.40 Billion in 2016 and is expected to reach $45.87 Billion by 2022, at a CAGR of 10.0% during the forecast period. Increase in incidence of target diseases and technological advancements and new product launches are the drivers that boost the growth of the market. On the flipside, the high cost of devices and Lack of knowledge on the usage on POC devices are the restraints that hamper the market growth. Increase in POC tests with multiplexing capabilities and a rise in emerging markets are the opportunities for the market.

Research Study Objectives:

• Define, estimate, and forecast the Point of Care Diagnostics market statistics by platform, product, prescription mode, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Point of Care Diagnostics market growth
• Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
• Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
• Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Point of Care Diagnostics Market Analysis
• Analysis and conclusions on the future Point of Care Diagnostics market outlook.

Top-down and bottom-up approaches are used to validate the Point of Care Diagnostics Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Point of Care Diagnostics Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Point of Care Diagnostics market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The Point of Care Diagnostics market segmentation is as follows:

By Product

• Tumor/Cancer Marker Testing Products
• Urinalysis Testing Products
• Cholesterol Testing Products
• Hematology Testing Products
• Drugs-of-Abuse Testing Products
• Fecal Occult Testing Products
• Cardiometabolic Testing Products
• Glucose Monitoring Products
• Infectious Disease Testing Products
• Coagulation Testing Products
• Pregnancy and Fertility Testing Products

By Prescription Mode

• Prescription-Based Testing
• OTC Testing

 By Platform

• Molecular Diagnostics
• Dipsticks
• Microfluidics
• Lateral Flow Assays
• Immunoassays

 By End Users

• Professional Diagnostic Centres
• Home Care
• Research Laboratories
• Other End Users

Geographical Analysis:

Point of Care Diagnostics Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Point of Care Diagnostics Market include:

• Scope Revision
• Geographic Analysis
• Company Profiles
• Historical Data & Forecasting
• Key Contact Persons in companies

Global Point of Care Diagnostics Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact on altering market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the significant Point of Care Diagnostics market players, such as
  • Trinity Biotech
  • PTS Diagnostics
  • Becton, Dickinson, and Company (BD)
  • EKF Diagnostics
  • Johnson & Johnson
• Along with these companies, many other companies are considered in the report while analysing the Global Point of Care Diagnostics competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.